Saturday June 6, 2020

Royalty Pharma given May deadline for Elan offer

Royalty Pharma must make an offer for Elan or announce it will not proceed by May 10th, the Irish Takeover Panel said.

3rd April, 2013
Elan chief executive Kelly Martin has said he doesn’t view the Royalty Pharma offer as credible.

Royalty Pharma must make an offer for Elan or announce it will not proceed by May 10th, the Irish Takeover Panel said.

The decision was made following representations by Elan and correspondence with advisers to both companies, the panel said in a statement today.

The deadline pressures New York-based Royalty to make a formal offer, following an “indicative proposal” on February 25th to buy Elan for about $6.5 billion, or $11 per American depository receipt....

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

The best writing and and the biggest stories of 2019 from the Business Post

Richie Oakley | 5 months ago

Denis O’Brien is back in court, residents continue to fight the Council on halting site and a row surfaces in government over rent control proposals

Leanna Byrne | 4 years ago